基本信息
浏览量:7
![](https://originalfileserver.aminer.cn/sys/aminer/icon/show-trajectory.png)
个人简介
I´m a Biomedical (qualified in Molecular Biology and Clinical Analysis). I worked as a technician in flow cytometry. I analyzed blood samples from HIV positive patients undergoing treatment, and prepared of bone marrow and peripheral blood cells from patients diagnosed with leukemia. I made Undergraduate Research at the UNIFESP. During this period, I was responsible for analyzing 6 potential drugs, which, in principle, had the ability to modulate the hematopoietic system. From this period, a scientific publication came out. After, I had the opportunity to start a Master's Degree. Thus, I analyzed the potential of 7 more drugs. One of them positively modulated the hematopoietic system in vivo and in vitro models. Which also originated another scientific publication. During my Undergraduate Research and Master's Degree, I worked with several animal models (nude mice, C57BL/6, C57BL/6 ob/ob and BALB/c), leukemic cells and human cells (in vivo, in vitro and ex vivo models). Essentially, my scientific background is related to hematology, radiotherapy, chemotherapy and mainly flow cytometry, where we implemented and developed a model for the analysis of hematopoietic cells (from murine and human leukemic cells). During the Master's period, I also had the opportunity to work as an author on other scientific articles. Then, I started my Doctorate at USP. As I had studied some drugs that had a modulatory and favorable potential in several models, I started a research with a total focus on the biological effect and mechanism of action this potential drug (important to mention that these data are confidential). Therefore, no articles were published during this period. Anyway, I participated in several scientific publications, the most important being Nature. During my PhD, I had the opportunity to work for a period in the USA, as a Research Associate Professor, where a group of researchers assisted in the implementation the evaluation the hematological and immune system, of a transgenic animal model and its relationship with cardiovascular alterations. After, I opened my startup in the area of biotechnology. I was Founder & CEO of Medical Peptide® (in 2019). Medical Peptide's goal was to develop a drug. In 2020 I was Founder of the Health Innovation Hub Medical Help. Through it, we assist professionals who develop high-impact/high-tech solutions (focused on health), with consulting and investment - in 2021, due to the pandemic, we ended our activities. My know-how comprises the area of technology transfer, patent, regulatory aspects, cell biology, bone marrow transplantation, toxicology, entrepreneurship and innovation.
研究兴趣
论文共 19 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Nutrition research (New York, N.Y.) (2023): 12-23
Amanda Nogueira-Pedro,Helena Regina Comodo Segreto,Kathryn D Held, Antonio Francisco Gentil Ferreira Junior,Carolina Carvalho Dias,Araceli Aparecida Hastreiter,Edson Naoto Makiyama,Edgar Julian Paredes-Gamero,Primavera Borelli,Ricardo Ambrósio Fock
引用0浏览0引用
0
0
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn